Sasaki Yutaro, Daizumoto Kei, Fukuta Kyotaro, Shiozaki Keito, Nishiyama Mitsuki, Utsunomiya Seiya, Kobayashi Saki, Seto Kosuke, Ueno Yoshiteru, Tomida Ryotaro, Kusuhara Yoshito, Fukawa Tomoya, Nakanishi Ryoichi, Yamaguchi Kunihisa, Yamamoto Yasuyo, Izaki Hirofumi, Takahashi Masayuki
Department of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Department of Urology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Asian J Endosc Surg. 2023 Oct;16(4):724-730. doi: 10.1111/ases.13234. Epub 2023 Jul 25.
This study was performed to evaluate the safety and efficacy of lymph node dissection (LND) during robot-assisted radical cystectomy (RARC) compared with open radical cystectomy (ORC).
From October 2003 to December 2021, 122 patients underwent LND during RARC and 103 patients underwent LND during ORC at Tokushima University Hospital and Tokushima Prefectural Central Hospital. We investigated the safety and efficacy of LND during RARC by comparing the surgical and oncological outcomes between the two groups.
The patients were significantly older in the RARC than the ORC group. The operative time was significantly shorter and the estimated blood loss was significantly lower in the RARC than the ORC group. Although the lymph node yield was significantly higher in the RARC than the ORC group, there was no significant difference in lymph node positivity between the groups. There was no significant difference in the incidence of local recurrence or distant metastasis between the two groups. The 5-year survival rates (overall survival, cancer-specific survival, and recurrence-free survival) were not different between the RARC and ORC groups.
This study suggests that the surgical and oncological safety and efficacy of LND during RARC are greater than those of LND during ORC. We believe that LND during RARC is a higher-quality procedure than LND during ORC.
本研究旨在评估机器人辅助根治性膀胱切除术(RARC)期间淋巴结清扫(LND)与开放性根治性膀胱切除术(ORC)相比的安全性和有效性。
2003年10月至2021年12月,德岛大学医院和德岛县立中央医院有122例患者在RARC期间接受了LND,103例患者在ORC期间接受了LND。我们通过比较两组的手术和肿瘤学结果,研究了RARC期间LND的安全性和有效性。
RARC组患者的年龄显著大于ORC组。RARC组的手术时间显著更短,估计失血量显著更低。虽然RARC组的淋巴结获取量显著高于ORC组,但两组之间的淋巴结阳性率没有显著差异。两组之间的局部复发或远处转移发生率没有显著差异。RARC组和ORC组的5年生存率(总生存率、癌症特异性生存率和无复发生存率)没有差异。
本研究表明,RARC期间LND的手术和肿瘤学安全性及有效性高于ORC期间的LND。我们认为,RARC期间的LND是比ORC期间的LND质量更高的手术。